Schroder Investment Management Group
SGMO

Schroder Investment Management Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Schroder Investment Management Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-79,370
Closed -$664K – 1385
2019
Q4 		$664K Sell
79,370
-36,471
-31% -$335K ﹤0.01% 1020
2019
Q3 		$1.06M Hold
115,841
– – ﹤0.01% 979
2019
Q2 		$1.25M Hold
115,841
– – ﹤0.01% 880
2019
Q1 		$1.1M Hold
115,841
– – ﹤0.01% 882
2018
Q4 		$1.33K Buy
+115,841
New +$1.44M ﹤0.01% 837

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schroder Investment Management Group's SGMO Position: Q1 2020 in Review

Schroder Investment Management Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 79,370 shares — an estimated $664K sold.

Schroder Investment Management Group first reported a position in SGMO in Q4 2018 and held it in 5 quarters. The position peaked at $1.25M in Q2 2019. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Schroder Investment Management Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 79,370 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $664K.
  • Schroder Investment Management Group first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 5 quarters.
  • Schroder Investment Management Group's SANGAMO THERAPEUTICS INC position peaked at $1.25M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Schroder Investment Management Group's 13F filing for Q1 2020, filed 15 May 2020.